A 13-year-old female presented with an invasive encapsulated follicular variant of papillary thyroid carcinoma
Rare thyroid cancer found in 13-year-old girl
This case report describes a single instance of invasive encapsulated follicular variant of papillary thyroid carcinoma in a 13-year-old fem…
A rare thyroid cancer was found in a 13-year-old girl. The case highlights a unique tumor type that is often misdiagnosed.
Immunohistochemical markers facilitate diagnosis of primary mucinous adenocarcinoma of the bladder in rare cases
Rare bladder cancer case reveals key diagnostic markers
This case report and literature review describes the diagnosis of primary mucinous adenocarcinoma of the bladder using a specific immunohist…
A 70-year-old woman's rare bladder cancer was diagnosed with a specific marker panel, with no recurrence at 6 months.
Acupuncture reduces Pittsburgh Sleep Quality Index scores in patients with breast cancer-related insomnia
Acupuncture may improve sleep quality for breast cancer patients
This meta-analysis of 2025 patients with breast cancer-related insomnia found that acupuncture significantly reduced Pittsburgh Sleep Qualit…
New data suggests acupuncture can help improve sleep quality for those dealing with insomnia related to breast cancer treatment.
Dexmethylphenidate significantly improves cancer-related fatigue compared to placebo with moderate evidence certainty
Methylphenidate shows modest relief for cancer related fatigue
This meta-analysis of 668 patients found that dexmethylphenidate (D-MPH) and methylphenidate (MPH) provide modest but significant reductions…
A new review suggests that certain forms of methylphenidate may slightly reduce exhaustion in people living with cancer.
FDA Approves Romvimza (vimseltinib) for Symptomatic Tenosynovial Giant Cell Tumor
FDA approves new drug Romvimza for rare joint tumor condition.
FDA approved Romvimza (vimseltinib) for adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection ma…
The FDA approved Romvimza (vimseltinib) for adults with symptomatic tenosynovial giant cell tumor (TGCT) when surgery would cause severe pro…
FDA Approves Sarclisa (isatuximab) for Multiple Myeloma in Three Combinations
FDA approves Sarclisa for multiple myeloma in three drug combinations.
The FDA approved Sarclisa (isatuximab) for adult patients with multiple myeloma in three combination regimens: with pomalidomide and dexamet…
The FDA approved Sarclisa (isatuximab) for multiple myeloma. It is used in three different combinations for patients at various stages of th…
FDA Approves Trelstar (triptorelin) for Advanced Prostate Cancer
FDA approves Trelstar for advanced prostate cancer treatment.
FDA approved Trelstar (triptorelin) for advanced prostate cancer. It is a GnRH agonist administered as intramuscular injection. Dosing sched…
The FDA approved Trelstar (triptorelin) to treat advanced prostate cancer. It lowers testosterone to slow cancer growth. This gives patients…
FDA Approves Trelstar (triptorelin pamoate) for Advanced Prostate Cancer
FDA approves new drug Trelstar for advanced prostate cancer.
The FDA approved Trelstar (triptorelin pamoate) for the treatment of advanced prostate cancer. It is a GnRH agonist administered as a single…
The FDA approved Trelstar (triptorelin pamoate) to treat advanced prostate cancer. It lowers testosterone levels to slow cancer growth. This…
FDA Approves Trelstar (triptorelin pamoate) for Advanced Prostate Cancer
FDA approves Trelstar for advanced prostate cancer treatment.
The FDA approved Trelstar (triptorelin pamoate) for the treatment of advanced prostate cancer. It is a GnRH agonist administered as a single…
The FDA approved Trelstar (triptorelin pamoate) for advanced prostate cancer. It lowers testosterone to slow cancer growth. This gives patie…
Catheterisation Linked to Small PSA Rise in Men
Urinary Catheters May Cause Small Increases in Prostate PSA Levels
A meta-analysis of 9 studies found that indwelling urethral catheterisation causes a small but statistically significant increase in serum P…
Short-term urinary catheters can cause small increases in prostate PSA levels, but these changes may not affect clinical decisions for short…
Multimodal strategies including bevacizumab and advanced radiotherapy techniques manage radiation-induced brain necrosis
New strategies help manage radiation-induced brain tissue damage
This narrative review synthesizes the pathogenesis, prevention, and treatment of radiation-induced brain necrosis (RBN) in patients with int…
Doctors are identifying new ways to prevent and treat brain tissue death caused by radiation during head and neck cancer treatments.
Multidisciplinary management of mixed adenoneuroendocrine carcinoma of the gallbladder involves surgery and adjuvant chemotherapy
Rare gallbladder cancer type shows specific genetic markers and traits
This case report and literature review describes the clinical management of a patient with mixed adenoneuroendocrine carcinoma of the gallbl…
A rare form of gallbladder cancer, known as GB-MANEC, was identified in a patient who underwent surgery and chemotherapy with no recurrence …